Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Great Lakes Ecological and Economic Protection Act of 2015
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2016 · first_quarter · Q1
Patent Reform Proposals; Patent Settlement Proposals.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2015 · fourth_quarter · Q4
Source: Senate LDA
Patent Reform Proposals; Patent Settlement Proposals.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2015 · third_quarter · Q3
Patent Reform Proposals; Patent Settlement Proposals.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2015 · second_quarter · Q2
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE